Recro Pharma owns and operates an 97,000 square foot, DEA-licensed facility that manufactures five commercial products that are commercialized by partners and receives royalties associated with the sales of these products.
http://ir.recropharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2.8 seconds
16x16
32x32
64x64
128x128
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
4
SITE IP
54.183.221.3
LOAD TIME
2.813 sec
SCORE
6.2
Investor Relations :: Recro Pharma, Inc. (REPH) | ir.recropharma.com Reviews
https://ir.recropharma.com
Recro Pharma owns and operates an 97,000 square foot, DEA-licensed facility that manufactures five commercial products that are commercialized by partners and receives royalties associated with the sales of these products.
ir.recropharma.com
Email Alerts :: Recro Pharma, Inc. (REPH)
http://ir.recropharma.com/email-alerts
Please fill out the form below to receive company press releases via email when they occur. Annual & Quarterly Reports. We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.
TOTAL PAGES IN THIS WEBSITE
1
صفحه اصلی - Rayan Vpn
خرید نقدی با کارت بانکی. بازیابی اکانت خریداری شده. خرید با کارت شارژ ایرانسل. آرشیو کلی مرکز آموزش. پنل کاربری مولتی سرویس. قبل و بعد از خرید. Telegram id : @rayanvpn. ماهیانه فقط 3500 تومان. ماهیانه فقط 3000 تومان. آخرین مطالب و تغییرات. حل مشکل the kerio vpn client service is not running در کریو. تحولی در پشتیبانی رایان. تغییر در تنظیمات همه سرورهای Cisco. لطفا ما را در تلگرام دنبال کنید! کانکشن هوشمند رایان نسخه 2. فروشگاه رایان ورود به فروشگاه. رایان وی پی ان. با بیش از 5 سال سابقه.
Rayonier | Investor Relations | Investor Relations
07/01/14 Allocation of Basis Between RYN and RYAM Common Stock. Q2 2015 Rayonier Inc Earnings Conference Call. August 06, 2015. 160;at 10:00 am ET. Q2 2015 Rayonier Inc Earnings Conference Call. Thursday, August 6, 2015 . 10:00 am ET . Click here for webcast. Q2 2015 Rayonier Earnings Presentation. Rayonier Reports Second Quarter 2015 Results (PDF). Rayonier Announces Closing of $550 Million Credit Facilities and Anticipated Recapitalization of New Zealand Joint Venture. Q2 2015 Rayonier Earnings Presen...
Круглый стол Годовые отчеты и сайты публичных компаний: как их оценивают эксперты?
И сайты публичных компаний:. Как их оценивают эксперты? Москва, Международный мультимедийный пресс-центр РИА Новости (Зубовский бульвар, д.4),. 9 февраля, 14.30 - 17.30. Ежегодно многие публичные компании принимают участие в конкурсах годовых отчетов и сайтов. В большинстве компаний подготовка годового отчета является серьезной процедурой, к которой привлекаются существенные интеллектуальные и творческие ресурсы. Но, как и в любом соревновании, по результатам есть победители и проигравшие. Кожевников Анд...
Investor Relations - Receptos
RMS Clinical Advisory Board. IBD Clinical Advisory Board. Annual Reports and Proxy. Annual Reports and Proxy. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put our financial performance into perspective. 011 ( 0.05%). Day High: 231.45. Day Low: 231.30. 4:00 PM ET on. Aug 14, 2015. Delayed at least 20 minutes. Jul 14, 2015. May 28, 2015. Jun 3, 2015 at 4:30 PM ET. May 20, 2015 at 12:00 PM ET.
Record Currency Management - Investors centre
Record Currency Management - Home. Financial information and reporting. Record is a specialist currency manager and provider of currency hedging services for institutional clients. Founded in 1983, Record has established a market leading position as a currency manager. Specifically, the Group has a leading position in managing Dynamic Hedging and Currency for Return for institutional clients. 44 (0)1753 852 222. Privacy and Cookie policy.
Investor Relations :: Recro Pharma, Inc. (REPH)
Recro Pharma owns and operates an 97,000 square foot, DEA-licensed facility that manufactures five commercial products that are commercialized by partners and receives royalties associated with the sales of these products.
IR센터 메인
Home | Investor Information
Rediff’s Secure Internet Platform wins CIO’s Choice 2016. LJ Road # 1, Mahim (West). 169; 2018 Rediff.com US.
Investor Relations | Investor Overview | Redknee
2016 In the Media. 2015 In the Media. 2014 In the Media. 2013 In the Media. Middle East and Africa. Railway SIM Profile Management. Railway Next Generation IN. Railway Subscription Management and Data Provisioning. Managed Services and Cloud Services. Stock Quote and Chart. Management and Board of Directors. Create New Business Models. Advance the Customer Experience. Live in Action Demos. Live in Action Demos. Real-time Monetization for a Real-time World. Redknee monetizes today’s digital world, providi...
home ~ REFIRE online ~ Real Estate Intelligence Report - Europe
Declaration of PropertyCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of PropertyItem: setField() should be compatible with Item: setField($field, $value, $safe = true) in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of DBFSCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class...
Investor Overview - Investors - REGENXBIO
160; 0.20. Data as of 01/12/17 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. REGENXBIO Provides Year-End 2016 Corporate Update. REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors. ROCKVILLE, Md. and CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) - REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based ...On track to d...
